Alain Weill
Impact in
- Family Practice top 1%
- Geriatrics and Gerontology top 1%
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
- Co-authors
- P. RicordeauH. AllemandFrançois AllaPhilippe TuppinRosemary Dray‐SpiraMahmoud ZureikJoël CosteAnke Neumann
- Journals
- Diabetes & Metabolism (14 papers)Pharmacoepidemiology and Drug Safety (10 papers)Vaccine (6 papers)The Lancet Regional Health - Europe (6 papers)JAMA Network Open (5 papers)
- Partner nations
- FranceUnited StatesSerbia
In The Last Decade
Alain Weill
216 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Family Practice 236
- Geriatrics and Gerontology 277
- Obstetrics and Gynecology 548
- Endocrinology, Diabetes and Metabolism 853
- Toxicology 150
Countries citing papers authored by Alain Weill
This map shows the geographic impact of Alain Weill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Weill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Weill more than expected).
Fields of papers citing papers by Alain Weill
This network shows the impact of papers produced by Alain Weill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Weill. The network helps show where Alain Weill may publish in the future.
Co-authors
The 25 scholars most cited alongside Alain Weill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 25 | |
| 10 | 2024 | 6 | |
| 11 | 2023 | 11 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 3 | |
| 14 | 2022 | 35 | |
| 15 | 2019 | 90 | |
| 16 | 2018 | 31 | |
| 17 | Treated diabetes: which trends between 2000 and 2009 in France? | 2010 | 7 |
| 18 | 2009 | 47 | |
| 19 | Abstract 1587: Impact of Universal Medical Coverage on Medical Care and Outcomes in Low Income Patients Hospitalised for Acute Myocardial Infarction: An Analysis From the French National Health Insurance Database | 2009 | 2 |
| 20 | [Modalities of follow-up on non-insulin treated diabetics treated in metropolitan France in 1998]. | 2000 | 8 |
About Alain Weill
Alain Weill is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism, General Health Professions, Geriatrics and Gerontology and Toxicology, having authored 230 papers that have together received 6.7k indexed citations. Recurring topics across this work include Healthcare Systems and Practices (39 papers), Pregnancy and Medication Impact (26 papers), Health, Medicine and Society (23 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers), SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (14 papers), Psoriasis: Treatment and Pathogenesis (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers). The work is most often cited by research in Family Practice (236 citations), Geriatrics and Gerontology (277 citations), Obstetrics and Gynecology (548 citations), Endocrinology, Diabetes and Metabolism (853 citations) and Toxicology (150 citations). Alain Weill has collaborated with scholars based in France, United States and Serbia. Frequent co-authors include P. Ricordeau, H. Allemand, François Alla, Philippe Tuppin, Rosemary Dray‐Spira, Mahmoud Zureik, Joël Coste, Anke Neumann, Jérôme Drouin and Pierre‐Olivier Blotière. Their work appears in journals such as Diabetes & Metabolism, Pharmacoepidemiology and Drug Safety, Vaccine, The Lancet Regional Health - Europe and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.